DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
173 hedge funds and large institutions have $1.4B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 66
69% less call options, than puts
Call options by funds: $1.51M | Put options by funds: $4.79M
Holders
173
Holding in Top 10
5
Calls
$1.51M
Puts
$4.79M
Top Buyers
| 1 | +$52.1M | |
| 2 | +$24.5M | |
| 3 | +$19.5M | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$10.8M |
| 5 |
Goldman Sachs
New York
|
+$8.31M |
Top Sellers
| 1 | -$22M | |
| 2 | -$12.7M | |
| 3 | -$10.2M | |
| 4 |
BM
Bridger Management
New York
|
-$9.05M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.03M |